201 related articles for article (PubMed ID: 24125968)
1. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
2. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population.
Zhang J; Zhang M; Jiang W; Wang L; Fu Z; Li D; Pang D; Li D
BMC Cancer; 2009 Nov; 9():394. PubMed ID: 19903360
[TBL] [Abstract][Full Text] [Related]
3. Association of B7-H4 gene polymorphisms in urothelial bladder cancer.
Özgöz A; Şamli M; Dinçel D; Şahin A; Ince Ü; Sağlican Y; Balci F; Şamli H
Turk J Med Sci; 2017 Apr; 47(2):443-446. PubMed ID: 28425229
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
[TBL] [Abstract][Full Text] [Related]
5. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
Chen XH; Li XQ; Chen Y; Feng YM
Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.
Cherdyntseva NV; Denisov EV; Litviakov NV; Maksimov VN; Malinovskaya EA; Babyshkina NN; Slonimskaya EM; Voevoda MI; Choinzonov EL
DNA Cell Biol; 2012 Mar; 31(3):306-16. PubMed ID: 21838531
[TBL] [Abstract][Full Text] [Related]
7. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Leaw SJ; Wang BY; Wang JL; Cao ZG; Gao JL; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(2):419-24. PubMed ID: 20300826
[TBL] [Abstract][Full Text] [Related]
8. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
11. The Immune Regulator VTCN1 Gene Polymorphisms and Its Impact on Susceptibility to Breast Cancer.
Tsai SM; Wu SH; Hou MF; Yang HH; Tsai LY
J Clin Lab Anal; 2015 Sep; 29(5):412-8. PubMed ID: 25385143
[TBL] [Abstract][Full Text] [Related]
12. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.
Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K
Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of FGFR2 gene polymorphism in women with breast cancer.
Salehi Z; Afzali S; Shabanipour S; Rahimi A
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):94-7. PubMed ID: 26025410
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
15. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Association between
Jahan N; Begum M; Barek MA; Aziz MA; Hossen MS; Bhowmik KK; Akter T; Islam MR; Abdulabbas HS; Islam MS
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107577
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
19. Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Saadatian Z; Gharesouran J; Ghojazadeh M; Ghohari-Lasaki S; Tarkesh-Esfahani N; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2014; 15(18):7955-8. PubMed ID: 25292094
[TBL] [Abstract][Full Text] [Related]
20. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
